Biologics Suppliers
Suppliers specializing in biologic drugs, recombinant proteins, monoclonal antibodies, and cell-based therapeutics alongside peptide offerings. Peptide CDMOs increasingly offer integrated biologics services as the distinction between synthetic peptides and recombinant proteins blurs for larger therapeutic molecules. EMA's June 2026 synthetic peptide guideline and the revised Annex 2 for biological medicinal products create a regulatory interface where synthetic peptides above certain molecular weight thresholds face overlapping quality requirements. ICH Q6B guidelines apply to recombinant peptide products of rDNA origin, while synthetic peptide generics referencing rDNA origin products follow specific FDA guidance pathways for active ingredient sameness assessment. Showing 4 listed suppliers.
Our directory lists suppliers offering biologics services across North America, Europe, Asia, Global regions. Supplier types include CDMO, Research Supplier, Manufacturer. Browse individual profiles below for detailed capability information, manufacturing standards, and quality documentation.
Directory listing last reviewed July 2026.
